Fingerprint
Dive into the research topics of 'Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American breast cancer intergroup trial E 2197'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically